Royal Bank Of Canada Genmab A/S Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Genmab A/S stock. As of the latest transaction made, Royal Bank Of Canada holds 797,813 shares of GMAB stock, worth $16.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

797,813

Previous 792,754 0.64%

Holding current value

$16.4 Million

Previous $19.9 Million 2.36%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.84 - $28.48 $120,606 - $144,080	5,059 Added 0.64%	797,813 $19.5 Million
Q2 2024 Aug 14, 2024	BUY	$25.13 - $30.27 $210,639 - $253,723	8,382 Added 1.07%	792,754 $19.9 Million
Q1 2024 Nov 05, 2024	SELL	$26.43 - $32.77 $221,536 - $274,678	-8,382 Reduced 1.06%	784,372 $23.5 Million
Q1 2024 May 15, 2024	BUY	$26.43 - $32.77 $3.79 Million - $4.7 Million	143,383 Added 22.37%	784,372 $23.5 Million
Q4 2023 Feb 14, 2024	SELL	$27.94 - $35.44 $5.44 Million - $6.9 Million	-194,821 Reduced 23.31%	640,989 $20.4 Million
Q3 2023 Nov 14, 2023	BUY	$35.27 - $42.24 $4.19 Million - $5.02 Million	118,762 Added 16.56%	835,810 $29.5 Million
Q2 2023 Aug 14, 2023	BUY	$37.4 - $42.94 $4.21 Million - $4.83 Million	112,462 Added 18.6%	717,048 $27.3 Million
Q1 2023 May 15, 2023	BUY	$34.88 - $43.22 $204,571 - $253,485	5,865 Added 0.98%	604,586 $22.8 Million
Q4 2022 Feb 14, 2023	SELL	$33.8 - $47.06 $2.9 Million - $4.04 Million	-85,839 Reduced 12.54%	598,721 $25.4 Million
Q3 2022 Nov 14, 2022	SELL	$31.52 - $373.61 $1.83 Million - $21.6 Million	-57,940 Reduced 7.8%	684,560 $22 Million
Q2 2022 Aug 15, 2022	BUY	$26.83 - $38.57 $1.94 Million - $2.79 Million	72,419 Added 10.81%	742,500 $24.1 Million
Q1 2022 May 16, 2022	BUY	$30.95 - $39.68 $773,626 - $991,841	24,996 Added 3.87%	670,081 $24.2 Million
Q4 2021 Feb 14, 2022	BUY	$35.87 - $47.12 $780,351 - $1.03 Million	21,755 Added 3.49%	645,085 $25.5 Million
Q3 2021 Nov 15, 2021	BUY	$41.55 - $48.72 $1.6 Million - $1.88 Million	38,585 Added 6.6%	623,330 $27.2 Million
Q2 2021 Aug 16, 2021	BUY	$32.88 - $44.57 $19.2 Million - $26.1 Million	584,745 New	584,745 $23.9 Million

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Genmab A/S Transaction History